Company registration number SC171963 (Scotland)
RENAISSANCE CARE (NO 7) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
RENAISSANCE CARE (NO 7) LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 8
RENAISSANCE CARE (NO 7) LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
266,146
202,531
Current assets
Debtors
5
1,143,433
1,116,298
Cash at bank and in hand
159,192
13,701
1,302,625
1,129,999
Creditors: amounts falling due within one year
6
(220,661)
(254,176)
Net current assets
1,081,964
875,823
Total assets less current liabilities
1,348,110
1,078,354
Provisions for liabilities
7
(48,655)
(36,982)
Net assets
1,299,455
1,041,372
Capital and reserves
Called up share capital
1,000
1,000
Share premium account
582,260
582,260
Profit and loss reserves
716,195
458,112
Total equity
1,299,455
1,041,372

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 27 May 2026 and are signed on its behalf by:
Mr L M Bain
Director
Company registration number SC171963 (Scotland)
RENAISSANCE CARE (NO 7) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 2 -
1
Accounting policies
Company information

Renaissance Care (No 7) Limited is a private company limited by shares incorporated in Scotland. The registered office is Archibald Hope House, Station Road, Musselburgh, Scotland, EH21 7PQ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Dow Investments PLC. These consolidated financial statements are available from its registered office, Archibald Hope House, Station Road, Musselburgh, Scotland, EH21 7PQ.

1.2
Going concern

At the time of approving the financial statements, the directors consider that the company has adequate resources to continue in operational existence for a period of not less than 12 months. The directors have reviewed their budgets and cashflow requirements and are satisfied that the group has sufficient cash reserves and net income trueand consider that this is sufficient to ensure short term liquidity and longer-term financial viability of the group. As such the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

 

Revenue represents fee income relating to the provision of care services. Fee income comprises residential, nursing and personal care services which are recognised when the delivery of service is completed. Fees invoiced in advance are included as deferred income until the service is completed.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

RENAISSANCE CARE (NO 7) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 3 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
20% straight line
Fixtures and fittings
20% reducing balance
Computers
25% straight line
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

RENAISSANCE CARE (NO 7) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

RENAISSANCE CARE (NO 7) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 5 -

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
106
127
3
Directors' remuneration
2025
2024
£
£
Remuneration paid to directors
55,013
49,825
RENAISSANCE CARE (NO 7) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 6 -
4
Tangible fixed assets
Leasehold improvements
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 December 2024
23,078
298,808
24,592
-
0
346,478
Additions
11,577
109,859
1,305
855
123,596
Disposals
(1,997)
-
0
-
0
-
0
(1,997)
At 30 November 2025
32,658
408,667
25,897
855
468,077
Depreciation and impairment
At 1 December 2024
2,766
128,231
12,950
-
0
143,947
Depreciation charged in the year
8,734
43,341
5,767
142
57,984
At 30 November 2025
11,500
171,572
18,717
142
201,931
Carrying amount
At 30 November 2025
21,158
237,095
7,180
713
266,146
At 30 November 2024
20,312
170,577
11,642
-
0
202,531
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
321,033
256,332
Amounts owed by group undertakings
738,563
756,061
Other debtors
83,837
103,905
1,143,433
1,116,298
6
Creditors: amounts falling due within one year
2025
2024
£
£
Amounts owed to group undertakings
5,530
57,894
Corporation tax
15,625
17,045
Other taxation and social security
-
0
147
Other creditors
199,506
179,090
220,661
254,176
7
Provisions for liabilities
2025
2024
£
£
Deferred tax liabilities
8
48,655
36,982
RENAISSANCE CARE (NO 7) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 7 -
8
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
48,655
36,982
2025
Movements in the year:
£
Liability at 1 December 2024
36,982
Charge to profit or loss
11,673
Liability at 30 November 2025
48,655
9
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

Senior Statutory Auditor:
Sharon Collins
Statutory Auditor:
Thomson Cooper
Date of audit report:
28 May 2026
10
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
12,281,963
11,499,636
RENAISSANCE CARE (NO 7) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 8 -
11
Related party transactions

The company has taken advantage of the exemption conferred by Financial Reporting Standard 102 Section 1A not to disclose inter-group transactions and balances on the grounds that 100% of the voting rights of the company are controlled within the group and that consolidated accounts are prepared by the ultimate holding company Dow Investments PLC and are publicly available at the address detailed below.

12
Parent company

The immediate parent company is Renaissance Care (Scotland) Limited, a company incorporated in Scotland which holds 100% of the ordinary share capital of the company during the current and previous financial year.

 

The directors consider the ultimate controlling party to be Dow Investments PLC, a company incorporated in Scotland, as a result of its controlling interest in Renaissance Care (Scotland) Limited. Dow Investments PLC is controlled by Mr R D Kilgour, director.

 

The accounts of Dow Investments PLC are available to the public via Companies House. The registered office of this company is Archibald Hope House, Station Road, Musselburgh, Scotland, EH21 7PQ. The company heads its largest group and smallest group in which the results of this company are included.

 

2025-11-302024-12-01falsefalsefalse28 May 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr R KilgourMrs A NeilsonMrs L BarnettMr L M BainSC1719632024-12-012025-11-30SC1719632025-11-30SC1719632024-11-30SC171963core:LeaseholdImprovements2025-11-30SC171963core:FurnitureFittings2025-11-30SC171963core:ComputerEquipment2025-11-30SC171963core:MotorVehicles2025-11-30SC171963core:LeaseholdImprovements2024-11-30SC171963core:FurnitureFittings2024-11-30SC171963core:ComputerEquipment2024-11-30SC171963core:MotorVehicles2024-11-30SC171963core:CurrentFinancialInstrumentscore:WithinOneYear2025-11-30SC171963core:CurrentFinancialInstrumentscore:WithinOneYear2024-11-30SC171963core:CurrentFinancialInstruments2025-11-30SC171963core:CurrentFinancialInstruments2024-11-30SC171963core:ShareCapital2025-11-30SC171963core:ShareCapital2024-11-30SC171963core:SharePremium2025-11-30SC171963core:SharePremium2024-11-30SC171963core:RetainedEarningsAccumulatedLosses2025-11-30SC171963core:RetainedEarningsAccumulatedLosses2024-11-30SC171963bus:Director42024-12-012025-11-30SC171963core:LeaseholdImprovements2024-12-012025-11-30SC171963core:FurnitureFittings2024-12-012025-11-30SC171963core:ComputerEquipment2024-12-012025-11-30SC171963core:MotorVehicles2024-12-012025-11-30SC1719632023-12-012024-11-30SC171963core:LeaseholdImprovements2024-11-30SC171963core:FurnitureFittings2024-11-30SC171963core:ComputerEquipment2024-11-30SC171963core:MotorVehicles2024-11-30SC1719632024-11-30SC171963bus:PrivateLimitedCompanyLtd2024-12-012025-11-30SC171963bus:SmallCompaniesRegimeForAccounts2024-12-012025-11-30SC171963bus:FRS1022024-12-012025-11-30SC171963bus:Audited2024-12-012025-11-30SC171963bus:Director12024-12-012025-11-30SC171963bus:Director22024-12-012025-11-30SC171963bus:Director32024-12-012025-11-30SC171963bus:FullAccounts2024-12-012025-11-30xbrli:purexbrli:sharesiso4217:GBP